Ad
ENTA - Enanta Pharmaceuticals Stock Trading
About | Enanta Pharmaceuticals Inc. (NASDAQ:ENTA)
None
Quote | Enanta Pharmaceuticals Inc. (NASDAQ:ENTA)
| Last: | $8.96 |
|---|---|
| Change Percent: | -3.14% |
| Open: | $9.25 |
| Close: | $9.25 |
| High: | $9.26 |
| Low: | $8.92 |
| Volume: | 32,358 |
| Last Trade Date Time: | 12/11/2023 03:00:00 am |
News | Enanta Pharmaceuticals Inc. (NASDAQ:ENTA)
-
2023-12-05 06:30:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
-
2023-11-30 15:34:48 ET Summary Two mid-stage studies RSVHR and RSVPEDs are being advanced using EDP-938 for RSV; data from at least one of these studies expected Q3 of 2024. Data to be released from phase 2a challenge study, using L-protein inhibitor EDP-323, expected in Q3 of 202...
Message Board Posts | Enanta Pharmaceuticals Inc. (NASDAQ:ENTA)
| Subject | By | Source | When |
|---|---|---|---|
| Investing in biotech can be risky so you | vinmantoo | investorshub | 05/09/2023 4:25:54 PM |
| Vin, its good. Stay optimistic. | Jake2234 | investorshub | 05/09/2023 12:43:10 PM |
| The after hours trades means lots of pain | vinmantoo | investorshub | 05/09/2023 5:15:17 AM |
| Yeah the market just tanked this thing and | Jake2234 | investorshub | 05/09/2023 1:10:04 AM |
| My agenda is to speak the truth. | vinmantoo | investorshub | 05/09/2023 12:33:11 AM |
News, Short Squeeze, Breakout and More Instantly...
Enanta Pharmaceuticals Inc. Company Name:
ENTA Stock Symbol:
NASDAQ Market:
Enanta Pharmaceuticals Inc. Website:
Ad
-
2023-12-05 06:30:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
-
Enanta Pharmaceuticals, Inc. (NASDAQ: ENTA), a clinical-stage biotechnology company dedicated to creating small molecule drugs with an emphasis on treatments for viral infections, today announced that Jay R. Luly, Ph.D., President and Chief Executive Officer, will participate in a fireside chat...
-
Shares of American Eagle Outfitters, Inc. (NYSE: AEO) declined during Tuesday’s session after the company reported third-quarter financial re...